Shyr, C.-R.; Wu, C.-F.; Yang, K.-C.; Ma, W.-L.; Huang, C.-P.
Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model. Cancers 2025, 17, 2448.
https://doi.org/10.3390/cancers17152448
AMA Style
Shyr C-R, Wu C-F, Yang K-C, Ma W-L, Huang C-P.
Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model. Cancers. 2025; 17(15):2448.
https://doi.org/10.3390/cancers17152448
Chicago/Turabian Style
Shyr, Chih-Rong, Ching-Feng Wu, Kai-Cheng Yang, Wen-Lung Ma, and Chi-Ping Huang.
2025. "Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model" Cancers 17, no. 15: 2448.
https://doi.org/10.3390/cancers17152448
APA Style
Shyr, C.-R., Wu, C.-F., Yang, K.-C., Ma, W.-L., & Huang, C.-P.
(2025). Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model. Cancers, 17(15), 2448.
https://doi.org/10.3390/cancers17152448
